| dc.rights.license | CC-BY-NC-ND | |
| dc.contributor.advisor | Grobbee, D.E. | |
| dc.contributor.author | Wang, Ziyi | |
| dc.date.accessioned | 2023-12-21T00:01:24Z | |
| dc.date.available | 2023-12-21T00:01:24Z | |
| dc.date.issued | 2023 | |
| dc.identifier.uri | https://studenttheses.uu.nl/handle/20.500.12932/45651 | |
| dc.description.abstract | This study investigates the prevalence and interrelations of renal impairment, diabetes, metabolic syndrome, and NASH in patients at high risk of cardiovascular disease (CVD). Conducted in primary care settings in the Netherlands, the research employs cross-sectional and cohort study designs to analyze data from 500 patients, aged 40-89, without symptomatic CVD history but identified for risk factor management. The study's objectives include determining the co-prevalence of these conditions and their impact on long-term cardiovascular outcomes. The findings aim to advance clinical insights, guide healthcare practices, and influence policy development regarding these co-morbidities in high cardiovascular-risk individuals. | |
| dc.description.sponsorship | Utrecht University | |
| dc.language.iso | EN | |
| dc.subject | We want to learn about kidney problems, diabetes, metabolic syndrome, and one of the liver diseases (non-alcoholic fatty hepatitis) among those at high risk of cardiovascular disease, and how the presence of renal impairment, diabetes, metabolic syndrome, and NASH impact long-term cardiovascular outcomes in high-risk patients. | |
| dc.title | Prevalence(co-occurrence) of Renal Impairment, Diabetes, Metabolic Syndrome, and NASH in Patients at a High Risk of Cardiovascular Disease | |
| dc.type.content | Master Thesis | |
| dc.rights.accessrights | Open Access | |
| dc.subject.keywords | Cardiovascular Health；Renal Impairment；Diabetes；Metabolic Syndrome；Non-Alcoholic Steatohepatitis (NASH) | |
| dc.subject.courseuu | Epidemiology | |
| dc.thesis.id | 26691 | |
